Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06261346 · ClinicalTrials.gov registry record · NA
Plasma Rich in Growth Factors in Corneal Endothelial Transplantation
A NA study of Fuchs Endothelial Dystrophy and Corneal Edema, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT06261346 is a NA study of Fuchs Endothelial Dystrophy and Corneal Edema that is actively recruiting participants, run by University of Miami. The registered enrollment target is 100 participants, below the 483-participant average among 7 other Fuchs Endothelial Dystrophy trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06261346, a NA study of Fuchs Endothelial Dystrophy and Corneal Edema, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to determine the safety and efficacy of brief intraoperative corneal endothelial graft incubation in plasma rich in growth factors (PRGF) for reducing postoperative endothelial cell loss.
Conditions Studied
Interventions
- PROCEDURE Endothelial keratoplasty
- BIOLOGICAL PRGF
Study Locations (2)
Florida
- Bascom Palmer Eye Institute - Miami
Indiana
- Price Vision Group - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-07-12 |
| Est. Completion | 2026-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06261346
The ClinicalTrials.gov registry entry for NCT06261346 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 483-participant average among 7 other Fuchs Endothelial Dystrophy trials with a reported enrollment target (79% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Fuchs Endothelial Dystrophy appearing as the primary indexed condition, and to 2 interventions - of which Endothelial keratoplasty is the first listed.
NCT06261346 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, Indiana.
Frequently Asked Questions
What is clinical trial NCT06261346 about?
NCT06261346 is a clinical study titled "Plasma Rich in Growth Factors in Corneal Endothelial Transplantation". The purpose of the study is to determine the safety and efficacy of brief intraoperative corneal endothelial graft incubation in plasma rich in growth factors (PRGF) for reducing postoperative endothelial cell loss.
What is the current status of trial NCT06261346?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-07-12. Estimated completion is 2026-10-30.
What conditions does trial NCT06261346 study?
This clinical trial studies the following conditions: Fuchs Endothelial Dystrophy, Corneal Edema.
What interventions are being tested in trial NCT06261346?
The interventions under investigation include: Endothelial keratoplasty (PROCEDURE), PRGF (BIOLOGICAL).
Who is sponsoring clinical trial NCT06261346?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06261346 being conducted?
This trial has 2 study locations across Florida, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fuchs Endothelial Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Eye Bank Pre-cut Donor Grafts for Endothelial Keratoplasty
COMPLETED · NA
-
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
RECRUITING · Phase 2
-
DISCOVER Study: Microscope-integrated Intraoperative OCT Study
RECRUITING
-
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
RECRUITING
-
Descemet Endothelial Thickness Comparison Trial II
RECRUITING · Phase 3
-
Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.